The Effect of Vascular Risk Factors on the Efficacy of Rivastigmine Patch and Capsule Treatment in Alzheimer's Disease

BACKGROUND: Vascular risk factors (VRF) may influence response to rivastigmine in Alzheimer's disease (AD). METHODS: AD patients who participated in a randomized, double-blind, placebo-controlled trial of rivastigmine patch and capsule treatment were stratified by baseline VRF status. Treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Farlow, M.R., Doraiswamy, P.M., Meng, X., Cooke, K., Somogyi, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199893/
https://www.ncbi.nlm.nih.gov/pubmed/22163241
http://dx.doi.org/10.1159/000328745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199893/
https://www.ncbi.nlm.nih.gov/pubmed/22163241
http://dx.doi.org/10.1159/000328745

Ejemplares similares